|
|
patented
fusion for sustained energy & fat burning |
Patented
Buffered Caffeine
A Fusion of Nature & Science
Named
“Breakthrough Product of the Year”
by Success Magazine
Featured
on the front page of the
Wall Street Journal
|
Buffered Caffeine™
is the only Buffered Caffeine that negates the fat-storing
and blood glucose imbalances caused by ingesting caffeine
and caffeine-drinks.
Buffered Caffeine™
is a Patented EDIBLE COMPUTER CHIP® that programs the
body to burn fat and to create maximum energy, instead
of storing fat into adipose tissue fat cells.
Energy
drinks and caffeinated beverages can cause fat-storage and
weight gain. The only methodology for blunting that
effect is Buffered Caffeine™.
|
|
 |
Buffered Caffeine™
was designed by leading Glycemic Index Researchers |
Why
is it important to have glycemic researchers design an energy
drink?
Because
energy drinks cause FAT-STORAGE in humans. What is the point
of energizing the body and stimulating fat-storage at the
same time?
The
only way to engineer an energy drink that does not stimulate
fat-storage is to incorporate the Glycemic Index (www.Glycemic.com)
and the Cephalic Response (www.CephalicResearch.com)
into the equation and to use Buffered Caffeine instead of
regular caffeine.
|
|
|
Biochemical
Actions of
Buffered Caffeine™
Research
& Science
|
| • |
Thermogenic
Fat-Burning |
| • |
High
Energy Levels |
| • |
Blunts
the Fat-Storing effects of Caffeine |
| • |
Certified
Low Glycemic Energy Matrix |
| • |
Combats
Stress-Related Eating |
| • |
Patented Hunger Control |
| • |
The Only
Non-Cephalic Buffered Caffeine |
|
PATENTED
CORE COMPOUND
The
Buffered Caffeine Patented Core Compound, known as Buffered Caffeine™,
is comprised of Buffered Caffeine, Chromium, and a specifically
designed Low Glycemic, Non-Cephalic Carbohydrate, known as
Sweet Infused Fruits™.
The
Buffered Caffeine™Edible Computer Chip®
was designed to be implanted (added) to any beverage, energy
drink, fat-burning drink, thermogenic drink, weight management
product, protein drink, and other products, for the purpose
of creating maximum adipose tissue (white and brown fat cells)
fat-burning and maximum glycemically balanced energy in humans.
WHAT IS AN EDIBLE COMPUTER CHIP®?
www.EdibleComputerChips.com
PATENT
PROTECTION:
BACKED BY A FULL U.S PATENT
No
other product can legally contain Caffeine or guarana, any
form of chromium, including picolinate, polynicotinate,
or yeast-chromium, with a Low Glycemic Carbohydrate without
violating our broad Patent. The Buffered Caffeine Patent has
been also been awarded for use in any beverage, including
coffee, tea, soda, cola, flavored/enhanced water, and sports
drinks.
OTHER
CAFFEINE-BUFFERS
There are currently (2009) no other Buffered
Caffeine products or Patents that buffer caffeine’s
proclivity to increase adipose tissue fat-storage, elicit
weight loss, block Cephalic Insulin Response, and moderate
glycemic response.
PATENT AWARDS
The
Buffered Caffeine™ Patent was named “Breakthrough
Product of the Year” by Success magazine, and was
featured on the front page of the Wall Street Journal
for having generated over $ 300 Million Dollars.
SWEET
INFUSED FRUITS™
The
Low Glycemic Carbohydrate utilized in Buffered Caffeine™ is 100%
natural Sweet Infused Fruits™.
www.SweetInfusedFruits.com
|
|
|
Patented
Buffered Caffeine |
The
following research projects have been conducted on Buffered Caffeine™
via Board Certified Human In Vivo Clinical Trials.
|
| •
|
Cellular
level thermogenesis, caffeine and DIT, methods for buffering
caffeine to eliminate fat-storage in fat cells, caffeine thermogenesis
|
| •
|
Identify
and quantify Pathogenesis of Obesity and Diet-Induced-Thermogenic
agents in humans
|
| •
|
Thermogenic
and fat-storing response of carbohydrates, sugars and sweeteners,
stimulation of fat-storing enzymes in humans, Brown Adipose
Tissue (BAT) and thermogenesis
|
| •
|
Internal
vs DIT thermogenesis, thermogenic capacity of cells and tissues,
UCP in mitochondria, Resistin, lipolytic actions in humans,
appestat centers of the brain
|
| •
|
Identification
and reduction of fat cell mass in humans, caloric conversion
info fat cells, human genetic code related to deposition of
adipose tissue body fat, N.E.A.T., fat thermostat in humans,
hypothalamus-related fat-storage
|
| •
|
LPL
gatekeepers for fat-storage in the fat cell, chromium and
thermogenesis, high-protein diets and reduced thermogenesis,
aging and adipose tissue fat accumulation, adipocyte lineage,
regulation of beta-3-adrenoceptor expression in white vs brown
fat cells
|
|
|
Board
Approved Human In Vivo Clinical Trials
2008-2009
|
|
Sweet Infused Fruits™
provides the base for Buffered Caffeine™ which provides the Pathobiochemical
Blunting Mechanism for Dietary induced Thermogenesis (DIT).
Sweet
Infused Fruits™ have been clinically proven to act as
an Anti-Carbohydrate in humans, preventing the shunting
of caffeine-beverages into adipose tissue fat cells.
|
Sweet
Infused Fruits ™ have undergone numerous Board Approved
Human In Vivo Clinical Trials in adults, children, and diabetics: |
| • |
Sweet Infused Fruits ™ are Certified Low Glycemic, and
have been clinically proven not to stimulate human Adipose
Tissue Fat-Storage. |
| • |
Sweet
Infused Fruits ™ are an important tool in the Obesogenics
epidemic. |
| • |
Sweet
Infused Fruits ™ do not activate primary Lipoprotein
Lipase human fat-storing mechanisms, and does not elevate
blood glucose or insulin levels in non-diabetics and type
2 diabetics. |
| • |
Sweet
Infused Fruits ™ have been shown to act as an “Anti-Carbohydrate”
in clinical trials. |
CLINICAL
TRIALS
Sweet
Infused Fruits ™ have been proven to act as an Anti-Carbohydrate
in six (6) separate Human In Vivo Clinical Trials; Adult
Diabetics, Adult Non-Diabetics, and Children under 17.
The
term Anti-Carbohydrate ™ has been assigned
to Sweet Infused Fruits™ due to their unique ability
to mitigate, block, and prevent the typical metabolic reaction
as related to every known carbohydrate, and as opposed to
all other carbohydrates.
Sweet
Infused Fruits ™ have been shown to be capable of
reversing the known and proven responses to high glycemic
foods, with benefits in post-prandial blood glucose, insulin,
and adipose tissue fat-storage via Lipoprotein Lipase.
Small doses of Sweet Infused Fruits ™ (7-8 g) consumed
30 or 60 minutes prior to consuming a high glycemic index
(50 g/carb), starchy food decreases the glycemic response
compared with either immediate or no Sweet Infused Fruits
™ treatments.
Further, this same dose of Sweet Infused Fruits ™
(7-8 g) reduces the glycemic response to a very large volume
of an extremely high glycemic (75 g/carb beverage, soda,
or sports drink.
Sweet Infused Fruits ™, unlike high glycemic sweeteners
and sugars, does not stimulate insulin secretion from pancreatic
ß-cells. Physiological sensing of plasma glucose is
primarily elucidated at the level of the pancreatic ß-cell.
These findings provide practical applications as the small
amount of Sweet Infused Fruits ™ required for this
response can easily be supplied as an adjunct to the diet.
CLINICAL TRIALS # 1 - 4
Sweet Infused Fruits ™ acutely and significantly mitigates
blood glucose and glycemic responses, and fat-storage properties
of oral ingestion of ice cream in humans.
CLINICAL
TRIAL # 5
Sweet Infused Fruits ™: Mitigation of adipose tissue
fat-storage, blood glucose and glycemic responses, Lipoprotein
Lipase, and insulin resistance in reaction to oral ingestion
of chocolate candy in humans.
CLINICAL
TRIAL # 6
Sweet Infused Fruits ™: Mitigation of the diabetic,
glycemic and metabolic responses in humans associated with
oral ingestion of Glucosamine, a known diabetic-risk-agent.
INSULIN & PRE-DIABETES IN CHILDREN:
INSULIN RESISTANCE
In 2008, renowned Pediatrician, Dr. William Sears*, stated
“Carbs are Killing our Children.” Dr.
Sears describes Pre-Diabetes in children as Insulin
Resistance, and has seen “narrowing of the arteries
in children as young as 3-years old, with insulin levels
of 38.
Normal insulin levels range from 11-19. The upper limit
insulin level is 29. In children who are Pre-Diabetic, insulin
levels reach as high as 38.
The Pre-Diabetic stage is the precursor to full blown type
2 diabetes and personifies Insulin Resistance. During this
stage of insulin imbalance, the body has lost the ability
to process sugar and high glycemic carbohydrates, and there
is not enough insulin to help the sugar get into the cells
and use it as energy. When this occurs, the sugar/carbohydrate
goes into storage (fat cells) instead of being utilized
as an energy fuel.
Repeated consumption of foods and beverages that stimulate
this response leads to obesity and type 2 diabetes in children
and adults. The obesity and Insulin Resistance epidemic
in children keeps escalating with no end in sight. As long
as children continue to consume foods and beverages that
elevate insulin levels and blood glucose levels, the plight
will continue.
Source: Dr. William Sears, Associate Clinical
Professor of Pediatrics, University of California, Irvine,
Harvard Medical School, Children's Hospital ((Boston), The
Hospital for Sick Children (Toronto); Associate Ward Chief
of Newborn Nursery and Associate Professor of Pediatrics.
INSULIN RESPONSE OF SWEET INFUSED
FRUITS™
Unlike glucose and other sugars, Sweet Infused Fruits ™
do not stimulate insulin secretion.
In clinical trials, “Orally ingested and IV administered
SIF were ineffective in eliciting postprandial
insulin secretion.”
DIABETIC APPLICATIONS
Sweet Infused Fruits ™ do not elicit a Cephalic Insulin
Response in humans, and do not stimulate insulin secretion
in humans. SIF are Low Glycemic, Non-Insulin-Cephalic, with
a Low Glycemic Load.
Therefore, Sweet Infused Fruits™ may be used in Type
2 diabetic formulations, including meal replacement drinks
and bars, medical feeding formulas, low glycemic ice cream
and candies, diabetic candies, caffeine-products and beverages,
and products for diabetic children.
Sweet Infused Fruits ™ have been demonstrated to serve
as a useful role in the dietary management of blood sugar
levels, since substitution of Sweet Infused Fruits ™
for other simple carbohydrates should lead to reduced post-prandial
glucose levels that will aid in overall control.
In persons with type 2 diabetes, the requirement for insulin
is greater than that produced by the pancreas. Sweeteners
that produce a lower secretion of insulin and blood glucose
are known to be beneficial for glucose metabolism.
RESULTS & BENEFITS
Stimulation of Lipoprotein Lipase (LPL) increases weight
gain, obesity, type 2 diabetes, and insulin-resistance.
LPL is the "Gatekeeper for fat-Storage in the fat
cell.” High glycemic and High-Cephalic ingredients,
foods and beverages stimulate LPL.
Abdominal fat Lipoprotein Lipase (LPL) activity contributes
to the increased risk for developing obesity-associated
diseases.
The leptin content of fat depots as well as plasma insulin
concentrations appear in our population as the main determinants
of adipose tissue LPL activity, adjusted by gender, depot
and BMI.
|
| • |
In type 2 diabetics, consuming 60 grams of Sweet Infused Fruits™
as compared to a typical diabetic meal (for 12 weeks) resulted
in decreases in both serum glucose (SG) and glycated hemoglobin
concentrations (GHC), which progressively decreased in the
group treated with Sweet Infused Fruits™ (SIF). In the
control group not using SIF, both SG and GHC increased. |
| • |
Oral
ingestion of Sweet Infused Fruits™ blunts LPL activity
and results in improvements in glycemic control and alterations
in apoprotein composition, which decrease risk of obese, diabetic,
and coronary events in humans. |
| • |
Utilizing
low glycemic sweeteners and carbohydrates, such as Sweet Infused
Fruits™, that do not stimulate blood glucose and insulin
levels, and do not trigger LPL, are essential in the long-term
prevention of obesity in humans. |
| • |
THERMOGENIC
EFFECT: When ingested, more energy is required to metabolize
Sweet Infused Fruits™, thus this process burns up more
calories. |
| • |
SATIETY:
It has been demonstrated that consumption of Sweet Infused
Fruits ™ prior to eating is particularly effective at
preventing hunger pangs and promotes a reduction in calorie
consumption during the meal itself. Eating snacks and drinks
containing Sweet Infused Fruits™ could help the weight
conscious and the clinically obese adhere to calorie-controlled
diets. |
| • |
ENERGY
DRINKS & SPORTS DRINKS: The Low Glycemic properties of
Sweet Infused Fruits™ (SIF) provide an ideal base for
sports drinks and sports products, as they help provide a
sustained source of energy, and do not cause reduced-sports-performance.
In energy drinks, SIF blunt adipose tissue fat-storage instigated
by caffeine and caffeinated-beverages, blunts LPL activity
and results in improvements in glycemic control and alterations
in apoprotein composition, which decreases risk of weight
gain, obesity, and diabetes in humans. |
| • |
GLYCEMIC
CONTROL: With its Low Glycemic Index and Load, Sweet Infused
Fruits™ can be consumed to improve glycemic control.
Sweet Infused Fruits™ have very little effect on blood
glucose and a negligible effect on the secretion of insulin. |
| • |
The
use of low glycemic sweeteners, such as Sweet Infused Fruits™,
further improves short and long-term treatment of obesity
and type 2 diabetes. |
| • |
Reducing the use of high glycemic carbohydrates, sugars, and
sweeteners improves incidence, risk, and development of obesity
and type 2 diabetes. |
| • |
Sweet
Infused Fruits™ enhance mineral absorption and this
offers considerable benefits, not only for the general population,
but also for special groups such as pregnant women who require
increased levels of minerals, especially iron and calcium. |
|
|
Buffered
Caffeine
Certifications
|
Buffered Caffeine™
has been independently Certified by:
|
|
Glycemic Research Institute®
License Issued and Authorized by:
U.S. Government Certification Program
United Kingdom Certification Program
Canada Government Certification Program
www.Glycemic.com |
|
Human
Sports Performance™
Certified Safe for Athletes
Meets the Guidelines of the U.S. Olympic Committee & the
World Anti-Doping Agency
www.HumanSportsPerformance.com
|
|
These
statements have not been evaluated by the Food & Drug Administration.
The products promoted herein are not intended to diagnose, treat,
cure, or prevent any disease. |
|
